Low-dose (12 Gy) TSEBT+Vorinostat Versus Low-dose TSEBT Monotherapy in Mycosis Fungoides

The purpose of this study is to determine if vorinostat combined with low-dose total skin electron beam therapy (TSEBT) offers superior clinical benefit (efficacy & safety) over low-dose TSEBT alone.

Principal Investigator

Stanford Investigator(s)

CONTACT INFORMATION

Primary Contact:
Cutaneous Lymphoma Coordinator
(650) 421-6370